| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/09/2023 | Blue Water Biotech, Inc. | | Grant | Common Stock | 150k | $0.00 | $0 | | 05/09/2023 |
| 08/22/2022 | Blue Water Biotech, Inc. | | Sale | Common Stock | 30.3k | $4.10 | $124.2k | | 08/18/2022 |
| 08/19/2022 | Blue Water Biotech, Inc. | | Sale | Common Stock | 76.8k | $4.21 | $323.7k | | 08/18/2022 |
| 08/18/2022 | Blue Water Biotech, Inc. | | Sale | Common Stock | 442.5k | $4.96 | $2.2M | | 08/18/2022 |
| 06/07/2022 | Clarus Therapeutics Holdings, Inc. | | Grant | Common Stock | 1.9k | $0.00 | $0 | | 06/07/2022 |
| 06/07/2022 | Clarus Therapeutics Holdings, Inc. | | Grant | Stock Option (Right to Buy) | 4.8k | $0.43 | $2.1k | | 06/07/2022 |
| 05/04/2022 | Blue Water Biotech, Inc. | | Grant | Stock Option | 200k | $6.45 | $1.3M | | 05/04/2022 |
| 04/25/2022 | Clarus Therapeutics Holdings, Inc. | | Other (disposition) | Common Stock | 65k | $0.00 | $0 | see footnote | 04/25/2022 |
| 04/25/2022 | Clarus Therapeutics Holdings, Inc. | | Other (acquisition) | Common Stock | 1.2M | $0.00 | $0 | | 04/25/2022 |
| 04/25/2022 | Clarus Therapeutics Holdings, Inc. | | Grant | Warrants | 3.4M | $11.50 | $39.6M | | 04/25/2022 |
| 12/12/2021 | Clarus Therapeutics Holdings, Inc. | | Grant | Stock Option (Right to Buy) | 9.6k | $4.78 | $45.9k | | 12/12/2021 |
| 12/12/2021 | Clarus Therapeutics Holdings, Inc. | | Grant | Common Stock | 3.8k | $0.00 | $0 | | 12/12/2021 |
| 09/09/2021 | Clarus Therapeutics Holdings, Inc. | | Other (disposition) | Common Stock | 135k | $0.00 | $0 | see footnote | 09/09/2021 |
| 09/09/2021 | Clarus Therapeutics Holdings, Inc. | | Exercise | Class B Common Stock | 1.4M | $0.00 | $0 | See footnote | 09/09/2021 |
| 09/09/2021 | Clarus Therapeutics Holdings, Inc. | | Grant | Warrant | 3.4M | $11.50 | $39.6M | See footnote | 09/09/2021 |
| 09/09/2021 | CLARUS THERAPEUTICS INC | CRXT | Grant | Warrant | 3.4M | $11.50 | $39.6M | See footnote | 09/09/2021 |
| 09/09/2021 | CLARUS THERAPEUTICS INC | CRXT | Exercise | Class B Common Stock | 1.4M | $0.00 | $0 | See footnote | 09/09/2021 |
| 09/09/2021 | CLARUS THERAPEUTICS INC | CRXT | Other (disposition) | Common Stock | 135k | $0.00 | $0 | see footnote | 09/09/2021 |
| 01/14/2021 | ORAGENICS INC | OGEN | Sale | Common Stock, $.001 par value | 870.9k | $0.98 | $856.5k | | 01/04/2021 |
| 01/13/2021 | ORAGENICS INC | OGEN | Sale | Common Stock, $.001 par value | 257.5k | $0.80 | $206k | | 01/04/2021 |
| 01/12/2021 | ORAGENICS INC | OGEN | Sale | Common Stock, $.001 par value | 629.7k | $0.73 | $460.2k | | 01/04/2021 |
| 01/11/2021 | ORAGENICS INC | OGEN | Sale | Common Stock, $.001 par value | 441.9k | $0.77 | $340.7k | | 01/04/2021 |
| 01/07/2021 | ORAGENICS INC | OGEN | Sale | Common Stock, $.001 par value | 324k | $0.84 | $272.2k | | 01/04/2021 |
| 01/06/2021 | ORAGENICS INC | OGEN | Sale | Common Stock, $.001 par value | 1000k | $0.60 | $600k | | 01/04/2021 |
| 01/05/2021 | ORAGENICS INC | OGEN | Sale | Common Stock, $.001 par value | 500k | $0.58 | $290.2k | | 01/04/2021 |
| 01/04/2021 | ORAGENICS INC | OGEN | Sale | Common Stock, $.001 par value | 176k | $0.52 | $91.5k | | 01/04/2021 |
| 12/02/2020 | ORAGENICS INC | OGEN | Sale | Common Stock, $.001 par value | 5M | $0.41 | $2.1M | | 12/02/2020 |